Ischaemic heart disease prevention
Christie, J.
NursingTimes 107(30-31): 20
2011
ISSN/ISBN: 0954-7762 PMID: 21957521 Document Number: 653802
Document emailed within 1 workday
Related Documents
Fejfar, Z.; Vrána, M. 1980: Sudden death in ischaemic heart disease--scope for prevention Casopis Lekaru Ceskych 119(50): 1368-1372Reinis, Z.; Pokorný, J.; Bazika, V.; Tiserová, J.; Gorican, K.; Horáková, D.; Stuchlíková, K.; Havránek, T.; Hrabovský, F. 1983: Epidemiology and prevention of ischaemic heart disease in automobile industry workers Czechoslovak Medicine 6(1): 53-54
Domarkene, S.B.; Glasunov, I.S.; Korsukovas, V. 1980: A survey of the opinions and attitudes of general practitioners in Kaunas to the prevention of ischaemic heart disease Cor et Vasa 22(5): 348-355
Kawecka-Jaszcz, K.; Pajak, A.; Jankowski, P. 2001: Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part I. Genesis and objectives Przeglad Lekarski 58(11): 953-955
Chotkowska, E.; Rywik, S.; Szostak, W.B.; Charzewska, J.; Sznajd, J.; Wasowicz, B.; Magdoń, M.; Nowacki, G. 1979: The prevalence of hypercholesterolemia in the male population covered by Polish trial on prevention of ischaemic heart disease Przeglad Lekarski 36(10): 737-741
Meimanaliev, T.S.; Shleifer, E.A.; Aitbaev, K.A.; Aitmurzaeva, G.T.; Gil'fanova, V.Sh.; Podgurskaya, L.P.; Abdurasulov, K.D.; Finger, E.M.; Ismailova, C.S.; Koshaliev, E.K. 1991: Prevalence of ischaemic heart disease risk factors among the male population in Frunze aged 40-59 years and results of a five-year prevention programme Cor et Vasa 33(6): 451-457
1980: W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators Lancet 2(8191): 379-385
Yarnell, J.W.; Limb, E.S.; Layzell, J.M.; Baker, I.A. 1992: Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies European Heart Journal 13(12): 1602-1605
Golan, D.T.; Kursbaum, A. 1976: Anti-heart autoantibodies in ischaemic heart disease patients Clinical and Experimental Immunology 26(1): 86-90
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108
Pandey, G.; Shukla, R.; Srimal, R.C.; Dhawan, B.N. 1983: Prevention of certain biochemical changes in acute ischaemic rabbit heart by verapamil Indian Journal of Medical Research 77: 248-254
Bashir, R.; Khan, A.; Yousaf, M. 1996: Angiographically documented coronary artery disease in asymptomatic middle aged men suspected of silent ischaemic heart disease Jpma. Journal of the Pakistan Medical Association 46(10): 225-228
Wojtczak, A.; Skretkowicz, J. 2007: Genetics in ischaemic heart disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 23(133): 5-8
Constantine, G.R.; Thenabadu, P.N. 1996: Use of aspirin in ischaemic heart disease Ceylon Medical Journal 41(4): 167-168
Lhotka, J.; Stuchlíková, E.; Klimesová, A. 1971: Changes in the pericardium in ischaemic heart disease Acta Universitatis Carolinae. Medica 17(7): 573-580
Law, M.R.; Wald, N.J. 1999: Homocysteine and ischaemic heart disease Haematologica 84 Suppl Eha-4: 57-60
Van Assche, F.A.; Aerts, L.; Holemans, K. 1994: Low birthweight and ischaemic heart disease Lancet 343(8899): 731-732
Violi, F.; Iuliano, L.; Iullano, L. 1997: Antioxidants and ischaemic heart disease Lancet 350(9078): 667-668
Tauheed, S.; Shoaib, S.; Kamal, A. 1993: Haematocrit values in ischaemic heart disease Jpma. Journal of the Pakistan Medical Association 43(2): 34-35